Unichem Laboratories Limited (UNICHEMLAB.NS)
INR 746.9
(-1.82%)
INR 746.9
(-1.82%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -49.57 Million | -850.9 Million | -2.59 Billion | 330.98 Million | 198.16 Million | -3.27 Billion |
| Net Income | -704.74 Million | -1.76 Billion | 219.68 Million | 514.79 Million | -482.1 Million | -574.35 Million |
| Depreciation & Amortization | 1.13 Billion | 1.13 Billion | 912.29 Million | 844.19 Million | 817.22 Million | 674.29 Million |
| Deferred income taxes | - | -105.61 Million | -205.49 Million | -176.78 Million | -384.61 Million | -393.5 Million |
| Stock-based compensation | 30.84 Million | 10.49 Million | 28.48 Million | 28.26 Million | 24.16 Million | 39.38 Million |
| Change in working capital | -1.02 Billion | -293.61 Million | -3.54 Billion | -696.65 Million | 535.75 Million | -2.64 Billion |
| Other non-cash items | 3.84 Billion | 167.01 Million | -6.8 Million | -182.83 Million | -312.25 Million | -374.13 Million |
| Investing Cash Flow | 498.34 Million | 2.02 Billion | 1 Billion | -735.57 Million | -412.1 Million | -2.86 Billion |
| Investments in PPE | -225.47 Million | -443.15 Million | -1.27 Billion | -2.87 Billion | -3.86 Billion | -1.94 Billion |
| Acquisitions | 89.41 Million | 63.73 Million | 1.64 Million | 4.22 Million | 58.82 Million | 27.63 Million |
| Investment purchases | -17.99 Million | -63.73 Million | -1.64 Million | -26.95 Million | -58.82 Million | -1.47 Billion |
| Sales/Maturities of investments | 652.38 Million | 2.36 Billion | 2.04 Billion | 1.86 Billion | 2.96 Billion | -27.63 Million |
| Other Investing Activities | 10 Thousand | 106.18 Million | 230.34 Million | 299.17 Million | 487.92 Million | 554.98 Million |
| Financing Cash Flow | -840.89 Million | -812.99 Million | 1.91 Billion | -1.21 Billion | -622.99 Million | -24.15 Million |
| Debt repayment | -784.79 Million | -256.63 Million | -95.15 Million | -834.08 Million | -165.89 Million | -489.08 Million |
| Dividends payments | -2.13 Million | -282.54 Million | -283.61 Million | -286.57 Million | -340.33 Million | -423.45 Million |
| Common Stock Repurchased | - | - | - | - | 165.89 Million | -489.08 Million |
| Common Stock Issuance | - | - | - | - | 1.03 Million | 2.12 Million |
| Other Financing Activities | -750.37 Million | -273.82 Million | 2.29 Billion | -91.24 Million | -283.69 Million | 1.37 Billion |
| Accounts receivables | -163.83 Million | -1.23 Billion | -2.77 Billion | 951.98 Million | 630.94 Million | 12.47 Million |
| Accounts payables | -68.21 Million | 1.19 Billion | -154.48 Million | -230.64 Million | 483.57 Million | -12.47 Million |
| Inventory | -794.46 Million | -250.07 Million | -618.81 Million | -1.41 Billion | -578.76 Million | -658 Million |
| Other working capital | -68.21 Million | - | - | - | - | -1.99 Billion |
| Cash at beginning of period | 1.85 Billion | 1.09 Billion | 774.6 Million | 2.31 Billion | 1.97 Billion | 6.66 Billion |
| Cash at end of period | 1.54 Billion | 1.83 Billion | 1.09 Billion | 774.6 Million | 2.26 Billion | 1.97 Billion |
| Capital Expenditure | -225.47 Million | -443.15 Million | -1.27 Billion | -2.87 Billion | -3.86 Billion | -1.94 Billion |
| Effect of forex changes on cash | - | 381.33 Million | - | 75.92 Million | 1.12 Billion | 1.47 Billion |
| Net cash flow / Change in cash | -309.28 Million | 745.55 Million | 317.35 Million | -1.54 Billion | 291.73 Million | -4.69 Billion |
| Free Cash Flow | -275.04 Million | -1.29 Billion | -3.86 Billion | -2.54 Billion | -3.66 Billion | -5.22 Billion |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 92.55 Million | -704.74 Million | -1.29 Billion | 839.9 Million | -244.87 Million | -6.68 Million |
| Depreciation & Amortization | - | 1.13 Billion | - | 278.57 Million | 294.54 Million | 287.71 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 30.84 Million | 30.84 Million | - | - | - |
| Change in working capital | - | -1.02 Billion | - | - | - | - |
| Other non-cash items | -92.55 Million | 3.84 Billion | 1.26 Billion | -839.9 Million | 244.87 Million | 6.68 Million |
| Investing Cash Flow | - | 498.34 Million | - | - | - | - |
| Investments in PPE | - | -225.47 Million | - | - | - | - |
| Acquisitions | - | 89.41 Million | - | - | - | - |
| Investment purchases | - | -17.99 Million | - | - | - | - |
| Sales/Maturities of investments | - | 652.38 Million | - | - | - | - |
| Other Investing Activities | - | 10 Thousand | - | - | - | - |
| Financing Cash Flow | - | -840.89 Million | - | - | - | - |
| Debt repayment | - | -784.79 Million | - | - | - | - |
| Dividends payments | - | -2.13 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -750.37 Million | - | - | - | - |
| Accounts receivables | - | -163.83 Million | - | - | - | - |
| Accounts payables | - | -68.21 Million | - | - | - | - |
| Inventory | - | -794.46 Million | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | 1.85 Billion | - | 645.58 Million | 56.49 Million | 1.85 Billion |
| Cash at end of period | - | 1.54 Billion | - | 1.2 Billion | 645.58 Million | 2.42 Billion |
| Capital Expenditure | - | -225.47 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -309.28 Million | - | 557.15 Million | 589.09 Million | 575.42 Million |
| Free Cash Flow | - | -275.04 Million | - | 557.15 Million | 589.09 Million | 575.42 Million |
601012
MSEXP
ARYACAPM
EDVMF
ADN
HOVS